© 2003 by Oxford University Press
© 2003 Oxford University Press
BRIEF COMMUNICATION |
Prostate-Specific Antigen Screening in Elderly Men
Affiliations of authors: HealthStat, Princeton, NJ (GLY); Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada (TAS); Dean and Betty Gallo Prostate Cancer Center, Cancer Institute of New Jersey, New Brunswick, NJ (GLY, SLY).
Correspondence to: Siu-Long Yao, MD, Dean and Betty Gallo Prostate Cancer Center, Cancer Institute of New Jersey, Rm. 204, 195 Little Albany St., New Brunswick, NJ 08901–1914 (e-mail: syao{at}aya.yale.edu)
Although the efficacy of prostate-specific antigen (PSA) screening for prostate cancer has not been established, it is widely used. However, despite the overall controversy regarding PSA screening, there has been general agreement that elderly men (i.e., those aged 75 years or older) should not be screened. By using a nationally representative sample of 7889 men who participated in the 2000 National Health Interview Survey, we found that the rate of PSA screening among men aged 75 or older was 32.5% (95% confidence interval [CI] = 28.8% to 36.1%), which was greater than that of fecal occult blood screening among men of the same age (22.8%, 95% CI = 19.2% to 26.4%) and was comparable with that of annual Pap smear screening among women aged 75 years or older (29.0%, 95% CI = 26.6% to 31.3%). Among screened elderly men, 88.4% (95% CI = 82.3% to 92.6%) reported that their doctor first suggested screening and 66.5% (95% CI = 59.7% to 73.3%) reported that the risks and benefits of screening were discussed before screening. We conclude that strategies are needed to increase understanding of the risks and benefits of PSA screening among elderly men.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. V. Hudson, P. Ohman-Strickland, J. M. Ferrante, G. Lu-Yao, A. J. Orzano, and B. F. Crabtree Prostate-Specific Antigen Testing among the Elderly in Community-Based Family Medicine Practices J Am Board Fam Med, May 1, 2009; 22(3): 257 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. McFall and M. Davila Gender, Social Ties, and Cancer Screening Among Elderly Persons J Aging Health, December 1, 2008; 20(8): 997 - 1011. [Abstract] [PDF]
|
|
|
|
 |
|
 H. B. Shim, S. E. Lee, H. K. Park, and J. H. Ku Histological Diagnosis of Prostate Cancer in Korean Men Aged 70 79 Years Jpn. J. Clin. Oncol., October 3, 2007; (2007) hym093v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Kerfoot, E. F. Holmberg, E. V. Lawler, E. Krupat, and P. R. Conlin Practitioner-Level Determinants of Inappropriate Prostate-Specific Antigen Screening Arch Intern Med, July 9, 2007; 167(13): 1367 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Walter, D. Bertenthal, K. Lindquist, and B. R. Konety PSA Screening Among Elderly Men With Limited Life Expectancies. JAMA, November 15, 2006; 296(19): 2336 - 2342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. Carter and W. B. Isaacs Improved Biomarkers for Prostate Cancer: A Definite Need J Natl Cancer Inst, June 2, 2004; 96(11): 813 - 815. [Full Text] [PDF]
|
|